Randy Hubbell, Armis Biopharma - Decreasing Quantity and Severity of Inflections | LSI USA '24

Armis Biopharma has five approved products that are ready to be commercialized/licensed out in dental, wound care, animal health, disinfectant and a hammer toe implant with an exciting pipeline including a chemical/biologic decontaminate supported by a $20M DoD grant.

LSI Europe ‘24 is filling fast. Secure your spot today to join Medtech and Healthtech leaders.

September 16-20, 2024 The Ritz-Carlton - Sintra, Portugal Register arrow